Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors.
Cancer Chemother Pharmacol. 2015 Feb;75(2):343-52. doi: 10.1007/s00280-014-2647-x. Epub 2014 Dec 20.
Cancer Chemother Pharmacol. 2015.
PMID: 25527204
Clinical Trial.
Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk-A re-analysis of eight GWASs.
Zhou F, Wang Y, Liu H, Ready N, Han Y, Hung RJ, Brhane Y, McLaughlin J, Brennan P, Bickeböller H, Rosenberger A, Houlston RS, Caporaso N, Landi MT, Brüske I, Risch A, Ye Y, Wu X, Christiani DC, Goodman G, Chen C; Transdisciplinary Research in Cancer of the Lung (TRICL) Research Team; Amos CI, Wei Q.
Zhou F, et al.
Mol Carcinog. 2017 Apr;56(4):1227-1238. doi: 10.1002/mc.22585. Epub 2016 Nov 15.
Mol Carcinog. 2017.
PMID: 27805284
Free PMC article.
Item in Clipboard
Cite
Cite